Anest. intenziv. Med. 2014;25(3):212-215

Candid sepsis as a complication in a polytrauma patientIntesive Care Medicine - Case Report

Sas Igor*, Straževská Eva, Hrdý Ondřej, Gál Roman
Klinika anesteziologie, resuscitace a intenzivní medicíny, Fakultní nemocnice Brnoa Lékařská fakulta Masarykovy univerzity, Brno

We describe a case of a patient with traumatic rupture of the spleen and liver, which was complicated by candid sepsis. The infection was endogenous, originating from the bowel. Empirical therapy with echinocandin was started. The diagnosis was confirmed by finding Candida krusei and Candida glabrata in abdominal tube secretion culture and also in blood culture. The sepsis was successfully treated. The patient died because of complications not related to the candid sepsis.

Keywords: traumatic rupture of spleen and liver; endogenous infection; candid sepsis; candidaemia; echinocandin

Received: November 15, 2013; Accepted: March 1, 2014; Published: June 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sas I, Straževská E, Hrdý O, Gál R. Candid sepsis as a complication in a polytrauma patient. Anest. intenziv. Med. 2014;25(3):212-215.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., Edmond, M. B. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nation-wide surveillance study. Clin. Infect. Dis., 2004, 39, p. 309-317. Go to original source... Go to PubMed...
    2. Pfaller, M. A., Diekema, D. J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev., 2007, 20, p. 133-163. Go to original source... Go to PubMed...
    3. Shorr, A. F., Lazarus, D. R., Sherner, J. H., Jackson, W. L., Morrel, M., Fraser, V. J., Kollef, M. H. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Crit. Care Med., 2007, 35, p. 1077-1083. Go to original source... Go to PubMed...
    4. Leon, C., Ruiz-Santana, S., Saavedra, P., Almirante, B., Nolla-Salas, J., Alvarez Lerma, F., Garnacho-Montero, J., Leon, M. A. A bedside scoring system (Candida score) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit. Care Med., 2006, 34, p. 730-737. Go to original source... Go to PubMed...
    5. Fluckiger, U., Marchetti, O., Bille, J., Eggimann, P., Zimmerli, S., Imhof, A., Garbino, J., Ruef, C., Pittet, D., Tauber, M., Glauser, M.,Calandra, T. Treatment options of invasive fungal infections in adults. Swiss Med. Weekly, 2006, 136, p. 447-463. Go to original source...
    6. Parkins, M. D., Sabuda, D. M., Elsayed, S., Laupland, K. B. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.J. Antimicrob. Chemother., 2007, 60, p. 613-618. Go to original source... Go to PubMed...
    7. Blumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel-Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., Wenzel, R. P. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin. Infect. Dis., 2001, 33, p. 177-186. Go to original source... Go to PubMed...
    8. Sobel, J. D., Rex, J. H. Invasive candidiasis: turning risk into a practical prevention policy? Clin. Infect. Dis., 2001, 33, p. 187-190. Go to original source... Go to PubMed...
    9. Pappas, Peter G. et al. Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 2009, 48, p. 503-35. DOI 10.1086/596757 Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.